Cited by 21Cervical Cancer and HPV ResearchReproductive tract infections researchWomen's cancer prevention and management

A population based study on human papillomavirus infection and associated risk factors among women of the remote South Andaman Island, India

Open access
Parvez, Rehnuma, Vijayachari, Paluru, Thiruvengadam, Kannan, Roy, Avijit, Saha, Mrinmoy Kumar, Ramasamy, Jawahar, Vins, Alwin, Biswas, Lipika +3 more·2024·BMC Women's Health

Abstract

Background: Human papillomavirus (HPV) is associated with cervical cancer and cervical dysplasia worldwide. Data on HPV prevalence in a region is important because it serves as a predictor of the likelihood of the population in that particular region acquiring cervical cancer. Moreover, with the availability of effective vaccines, the public health system must be aware of the preponderance of HPV to implement the vaccine. The present study was designed to understand the prevalence of HPV and associated factors among the women of South Andaman Island. Methods: A cross-sectional study was conducted among married women of reproductive age (18–59 years) from South Andaman District from 2018 to 2022. Cervical scrapes were collected from participants after obtaining informed written consent for HPV molecular testing (HPV DNA) such as PCR assay. Demographic data was collected using a standard questionnaire and statistical analyses were performed to determine the associated factors. Results: The study showed prevalence of HPV as 5.9%(95% CI: 3.9–7.9) and prevalence of HR-HPV16 was 4.1% (95% CI 2.6 – 5.5) and HR-HPV18 prevalence was 1.8(95% CI: 0.6–3). The independent factors associated the HPV positivity were age above 55 years, menopause, post-menopausal bleeding, blood-stained vaginal discharge and loss of weight. Age was associated with all HPV infections among the South Andaman women. Conclusions: HPV 16 was reported as the predominant high risk HPV type circulating among women of South Andaman. Cervical cancer and precancerous lesions were significantly associated with HPV positivity and High risk HPV 16. Based on the knowledge of the risk factors associated with HPV, implementation of stronger public health awareness and prophylactic HPV vaccination is crucial among the women of this remote island.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12905-024-02967-7

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 39 · Cited by 21

Research works printed but not linked: 40

  1. [2]Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):e197–206. 10.1016/S2214-109X(22)00501-0. PMC9848409 36528031 · DOI · Paper page
  2. [4]Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1). 10.1128/CMR.16.1.1-17.2003. PMC145302 12525422 · DOI · Paper page
  3. [5]Muñoz N. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27. 12571259
  4. [6]Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88(1). 10.1038/sj.bjc.6600688. PMC2376782 12556961 · DOI
  5. [7]Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27. 10.1056/NEJMoa021641. 12571259 · DOI · Paper page
  6. [8]Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Womens Health. 2015;7:405–414. Published 2015 Apr 16. 10.2147/IJWH.S50001. PMC4404964 25931830 · DOI
  7. [9]Bhatla N, Lal N, Bao YP, Ng T, Qiao YL. A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine. 2008;26(23). 10.1016/j.vaccine.2008.03.047. 18450340 · DOI
  8. [10]Munjal K, Adamson CS, Rajendran V, Nandedkar S, Cooper K, Evans MF. Human papillomavirus type distribution in invasive cervical cancers from Madhya Pradesh: implications for vaccination programs in central India. Int J Gynecol Pathol. 2014;33(5). 10.1097/PGP.0000000000000083. 25083972 · DOI · Paper page
  9. [11]Das BC, Gopalkrishna V, Hedau S, Katiyar S. Cancer of the uterine cervix and human papillomavirus infection. Current science. 2000;78(1):52–63.
  10. [12]Sabeena S, Bhat PV, Kamath V, Bhat ShK, Nair S, Ravishankar N, et al. Community-Based Prevalence of Genital Human Papilloma Virus (HPV) Infection: a Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2017;18(1):145-154. 10.22034/APJCP.2017.18.1.145. PMC5563091 28240509 · DOI
  11. [14]Parvez R, Hedau S, Bhattacharya D, Bhattacharjee H, Muruganandam N, Das BC, et al. High-risk HPV infection among the tribal and non-tribal women of the Andaman and Nicobar Islands, India. Public Health. 2012;126(1):67-9. 10.1016/j.puhe.2011.09.018. 22130478 · DOI
  12. [16]Hermansson RS Olovsson M Hoxell E Lindström AK HPV prevalence and HPV-related dysplasia in elderly women PLoS ONE 2018 13 1 e0189300 10.1371/journal.pone.0189300 29320507 PMC5761845 · DOI
  13. [19]Nayar R, Wilbur DC. The Pap Test and Bethesda 2014 “The reports of my demise have been greatly exaggerated.”(after a quotation from Mark Twain). Acta Cytologica. 2015;59(2):121–32. 25997404
  14. [20]Das BC, Sharma JK, Gopalkrishna V, Das DK, Singh V, Gissmann L, et al. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol. 1992;36(4):239-45. 10.1002/jmv.1890360402. 1315836 · DOI
  15. [22]Nigam A, Saxena P, Acharya AS, Mishra A, Batra S. HPV Vaccination in India: Critical Appraisal. ISRN Obstet Gynecol. 2014;2014:394595. 10.1155/2014/394595. PMC3967597 25006481 · DOI
  16. [24]de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453-9. 10.1016/S1473-3099(07)70158-5. 17597569 · DOI · Paper page
  17. [25]Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12). 10.1086/657321. 21067372 · DOI
  18. [26]Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349-59. 10.1002/ijc.27485. 22323075 · DOI · Paper page
  19. [27]Sonkar SC Yadav S Malla N Dhanda RS Khurana S Bagga R Saluja D Yadav M Evaluation of DNA based techniques for the diagnosis of human vaginal trichomoniasis in North Indian population Brit Microbiol Res J 2016 17 6 1 2 10.9734/BMRJ/2016/29557 · DOI
  20. [28]Sarkar K, Pal R, Bal B, Saha B, Bhattacharya S, Sengupta S, et al. Oncogenic HPV among HIV infected female population in West Bengal, India. BMC Infect Dis. 2011;11:72. 10.1186/1471-2334-11-72. PMC3079649 21418663 · DOI
  21. [29]Sureshkumar BT Shanmughapriya S Das BC Natarajaseenivasan K A population-based study of the prevalence of HPV in three districts of Tamil Nadu India Int J Gynaecol Obstet 2015 129 1 58 61 10.1016/j.ijgo.2014.10.025 25556078 · DOI
  22. [30]Sharma K Kathait A Jain A Kujur K Raghuwanshi S Bharti AC Higher prevalence of human papillomavirus infection in adolescent and young adult girls belonging to different Indian tribes with varied socio-sexual lifestyle PLoS ONE 2015 10 5 e0125693 10.1371/journal.pone.0125693 25954813 PMC4425665 · DOI
  23. [31]Gheit T Vaccarella S Schmitt M Pawlita M Franceschi S Sankaranarayanan R Prevalence of human papillomavirus types in cervical and oral cancers in central India Vaccine 2009 27 5 636 639 10.1016/j.vaccine.2008.11.041 19056450 · DOI · Paper page
  24. [32]Munjal K Adamson CS Rajendran V Nandedkar S Cooper K Evans MF Human papillomavirus type distribution in invasive cervical cancers from Madhya Pradesh: implications for vaccination programs in central India Int J Gynecol Pathol 2014 33 5 531 536 10.1097/PGP.0000000000000083 25083972 · DOI · Paper page
  25. [33]Franceschi S Rajkumar R Snijders PJ Arslan A Mahe C Plummer M Papillomavirus infection in rural women in southern India Br J Cancer 2005 92 3 601 606 10.1038/sj.bjc.6602348 15668709 PMC2362069 · DOI · Paper page
  26. [35]Gupta S Purwar S Gupta P Halder A Gupta A Pushpalatha K John JH Burden and associated genotype patterns of high-risk human papilloma virus infection and cervical cytology abnormalities among women in Central India Infect Dis Obstet Gynecol 2022 18 2022 PMC9132658 35634175
  27. [36]Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813-9. 10.1001/jama.297.8.813. 17327523 · DOI
  28. [37]Manhart LE Holmes KK Koutsky LA Wood TR Kenney DL Feng Q Kiviat NB Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy Sex Transm Dis 2006 1 502 508 10.1097/01.olq.0000204545.89516.0a 16572039 · DOI
  29. [38]Mbulawa ZZ, Coetzee D, Williamson AL. Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status. BMC Infect Dis. 2015;15:459. Published 2015 Oct 26. 10.1186/s12879-015-1181-8. PMC4624185 26502723 · DOI
  30. [39]Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008;43(4 Suppl):S5-S25.e41. 10.1016/j.jadohealth.2008.07.009. 18809145 · DOI
  31. [40]Tao L Han L Li X Gao Q Pan L Wu L Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing BMC Public Health 2014 14 1 9 10.1186/1471-2458-14-1185 25410572 PMC4256817 · DOI
  32. [41]Rodríguez AC Schiffman M Herrero R Hildesheim A Bratti C Sherman ME Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection J Natl Cancer Inst 2010 102 5 315 324 10.1093/jnci/djq001 20157096 PMC2831050 · DOI
  33. [42]Mohamed NG Abidin NZ Law KS Abe M Suzuki M Muhamed AM Singh R The effect of wearing sanitary napkins of different thicknesses on physiological and psychological responses in Muslim females J Physiol Anthropol 2014 33 1 7 10.1186/1880-6805-33-28 25189184 PMC4177679 · DOI
  34. [43]Alkire S. The missing dimensions of poverty data: Introduction to the special issue. Oxford development studies. 2007;35(4):347–59.
  35. [44]Vostral SL. Rely and Toxic Shock Syndrome: a technological health crisis. Yale J Biol Med. 2011;84(4):447–59. PMC3238331 22180682
  36. [45]Mitchell SM Sekikubo M Biryabarema C Byamugisha JJ Steinberg M Jeronimo J Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa Am J Obstet Gynecol 2014 210 1 81 e1 10.1016/j.ajog.2013.08.038 23999419 · DOI · Paper page
  37. [46]Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev. 2001;10(2):101–6. 11219765
  38. [47]Katki HA Kinney WK Fetterman B Lorey T Poitras NE Cheung L Demuth F Schiffman M Wacholder S Castle PE Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice Lancet Oncol 2011 12 7 663 72 10.1016/S1470-2045(11)70145-0 21684207 PMC3272857 · DOI
  39. [48]Schiffman M, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA. Relative performance of HPV and cytology components of cotesting in cervical screening. J National Cancer Institute. 2018;110(5):501–8. PMC6279277 29145648
  40. [49]Jans L Zetterström K Bergengren L Helenius G The value of adding a single co-test in HPV primary screening Prev Med 2021 1 149 106617 10.1016/j.ypmed.2021.106617 33984370 · DOI

Authors
Parvez, R., Vijayachari, P., Thiruvengadam, K., Roy, A., Saha, M. K., Ramasamy, J., Vins, A., Biswas, L., Vaz, A., Kaur, H., & Nagarajan, M.
Affiliations
  • Indian Council of Medical Research (IN)
  • Regional Medical Research Centre (IN)
  • Govind Ballabh Pant Hospital (IN)
  • Vinayaka Missions University (IN)
Corresponding author
Parvez, Rehnuma
Venue
BMC Women's Health
Published
2024-02-23
Volume
24
Issue
1
Pages
139-139
ISSN
1472-6874 (ISSN-L)
OpenAlex
W4392101696
Cited by
21
References
39
Citations by year
2026: 9 · 2025: 10 · 2024: 2
FWCI
6.41
Type
journal article
Language
en
Open access
Locations
  • BMC Women s Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Indian Council of Medical Research (File no. Tribal/117/2020-ECD-II (2020-5180))
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords
human papillomavirus, HPV prevalence, high-risk HPV, HPV16, HPV 18, risk factors, cervical cancer, cervical intraepithelial neoplasia, menopause, postmenopausal bleeding, South Andaman, remote island populations, HPV vaccination
MeSH terms
Adolescent, Adult, Uterine Cervical Neoplasms, Cross-Sectional Studies, Female, Humans, India, Middle Aged, Risk Factors, Prevalence, Papillomaviridae, Papillomavirus Infections, Human papillomavirus 16, Papillomavirus Vaccines, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review